|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/564 |
| (11) | Patento numeris | 3250927 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16704525.1 |
| Europos patento paraiškos padavimo data | 2016-01-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-12-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/015344 |
| Data | 2016-01-28 |
| (87) | Numeris | WO 2016/123329 |
| Data | 2016-08-04 |
| (30) | Numeris | Data | Šalis |
| 201562108914 P | 2015-01-28 | US |
| (72) |
TOWNSEND, Michael, US
SETIADI, Alvernia Francesca, US
STATON, Tracy, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | GENE EXPRESSION MARKERS AND TREATMENT OF MULTIPLE SCLEROSIS |
| GENE EXPRESSION MARKERS AND TREATMENT OF MULTIPLE SCLEROSIS |